Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Belle Health vs WellMedRx

Belle Health
Graded #48

Higher grade

vs+22.5
WellMedRx
Graded #457

Lower grade

The verdict

Belle Health takes it — 77/100 to 54.5/100.

Belle Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Belle Health is a national DTC telehealth platform offering compounded semaglutide and tirzepatide with flat-rate pricing — the same monthly cost at every dose, with no escalation surcharge as you titrate up.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBelle Health +47
92
45
Dose & formulationBelle Health +32
72
40
Clinical oversightWellMedRx +2
71
73
Labs & monitoringBelle Health +12
72
60
FulfillmentBelle Health +25
85
60
Contract termsEven
55
55
Belle Health · left barWellMedRx · right bar

The numbers

MetricBelle HealthWellMedRx
WeighScore77/10054.5/100
GradeC+C
Scorecard rank#48#457
Semaglutide$119/moNot disclosed
Tirzepatide$199/mo (all doses, 3-month plan, compounded)Not disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Belle Health

Graded #48 · C+

Strengths

  • Five named compounding pharmacy partners disclosed (Striker, Strive, OptioRx, Enovex, Braun PharmaCare)
  • Flat-rate pricing — $119/mo semaglutide, $199/mo tirzepatide — doesn't rise at higher doses
  • Free weekly registered-dietitian sessions included
  • Operating since 2017
  • LegitScript Certified

Where it loses points

  • $199 tirzepatide price requires a 3-month bundle commitment
  • Compounded medications are not FDA-approved
  • Multi-pharmacy model — formulations may differ across orders
  • FDA issued this company a warning letter dated 20 February 2026; the letter is public in FDA's warning-letter database
WellMedRx

Graded #457 · C

Strengths

  • Named licensed pharmacy partner (Mycelium Pharmacy)
  • Clinical care delivered through OpenLoop Health, an established clinician network
  • Multi-product platform — one account covers weight loss, TRT, hair, and sexual health
  • HIPAA-compliant badge on the home page

Where it loses points

  • Monthly pricing not shown until after intake
  • State coverage not disclosed — only 'a licensed professional in your state'
  • No LegitScript registration visible on the home page
  • No NABP .pharmacy seal
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard